Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    "Polymorphic catecholergic ventricular tachycardia"
Show Display Options
Rank Status Study
1 Completed Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Condition: Catecholaminergic Polymorphic Ventricular Tachycardia
Intervention: Drug: flecainide
2 Not yet recruiting Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Condition: Catecholaminergic Polymorphic Ventricular Tachycardia
Interventions: Drug: Atropine;   Procedure: Exercise treadmill test
3 Enrolling by invitation Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias
Conditions: Inherited Cardiac Arrythmias;   Long QT Syndrome (LQTS);   Brugada Syndrome (BrS);   Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT);   Early Repolarization Syndrome (ERS);   Arrhythmogenic Cardiomyopathy (AC, ARVD/C);   Hypertrophic Cardiomyopathy (HCM);   Dilated Cardiomyopathy (DCM);   Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy);   Normal Control Subjects
Intervention:
4 Recruiting Genetic Markers of Cardiovascular Disease in Epilepsy
Conditions: Epilepsy;   Seizures;   Syncope;   Channelopathy;   Cardiomyopathies
Intervention:

Study has passed its completion date and status has not been verified in more than two years.